AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05604222 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mirabegron 50 MG
Description: Medication to treat overactive bladder
Study NCT05604222 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief Behavioral Treatment for Insomnia
Description: A behavioral intervention for insomnia
Study NCT05460117 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Radiofrecuency
Description: he use of 448kilohertz capacitive resistive monopolar radiofrequency as the focus of the treatment looking for improve the quality of the tissue is still to be explored.
Study NCT05953246 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Neutral labels
Description: Participants view neutral labels (QR codes with and without neutral text) for menu items
Study NCT05953246 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Numeric text-only sustainability labels
Description: Participants view labels with numeric text depicting the greenhouse gas emissions associated with production of the menu item
Study NCT05953246 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Endorsement text-only sustainability labels
Description: Participants view labels using text to endorse menu items as having low environmental impact
Study NCT05953246 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Endorsement icon-only sustainability labels
Description: Participants view labels using icons to endorse menu items as having low environmental impact
Study NCT04796324 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ixabepilone Injection
Description: Ixabepilone 40 mg/m2 is administered as a 3-h intravenous infusion Day 1 in a 3-week cycle
Study NCT05782816 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxytocin
Description: Low dose oxytocin
Study NCT05782816 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxytocin
Description: High dose oxytocin
Study NCT06537063 — intervention group
Intervention type: OTHER
Intervention: G4 DNAm test
Description: Detection of DNA methylation (DNAm) around G-quadruplex loci in cell-free DNA from blood.
Study NCT05941520 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acolbifene Hydrochloride
Description: Given PO
Study NCT05941520 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo collection of blood
Study NCT05941520 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biospecimen Collection
Description: Undergo collection of blood
Study NCT05941520 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Mammography
Description: Undergo 3D mammography
Study NCT05941520 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Random Periareolar Fine-Needle Aspiration
Description: Undergo RPFNA
Study NCT05941520 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Random Periareolar Fine-Needle Aspiration
Description: Undergo RPFNA
Study NCT05941520 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tamoxifen
Description: Given PO
Study NCT06453083 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablets will be dispensed to the participants for 6-days.
Study NCT06453083 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Medrol
Description: Medrol tablets will be dispensed to the participants for 6-days.
Study NCT05953246 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Endorsement text-plus-icon sustainability labels
Description: Participants view labels using text and icons to endorse menu items as having low environmental impact
Study NCT05230108 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Advanced Triage
Description: Advanced triage is an intervention that allows the emergency nurse to resolve health problems of low clinical complexity. All actions are aimed at resolving a health problem based on a protocol previously agreed upon by a multidisciplinary team.
Study NCT05039645 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Patient specific, clinician determined Intervention
Description: Data collected from the DFS device will be transmitted to a remote, cloud-based server for daily review using the SRI software. If a temperature difference of >2.2°C between similar points on the left and right feet is identified for 2 consecutive scans, or visible signs of skin damage are observed, the site will be notified and sent a report containing the findings. Once notified the site will contact the patient by telephone and determine the best course of action based on standard practices (e.g. offloading, attending an appointment).
Study NCT05808491 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: online resilience intervention
Description: online resilience intervention were presented in four 60-minute sections, once a week for four weeks embracing four sections
Study NCT04954781 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: Tislelizumab will be initiated on day 14 after the first TACE session. Tislelizumab will be administered at 200 mg i.v. every 3 weeks until documented disease progression, development of unacceptable toxicity, participant request, or withdrawal of consent.
Study NCT04954781 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: TACE
Description: TACE is performed by using drug-eluting beads. TACE treatment starts on day 0. The second TACE will be repeated on day 28 (± 5 days) if necessary per Investigator's decision.
Study NCT05016921 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TcMS
Description: Transcutaneous magnetic stimulation targeting the stellate ganglion
Study NCT04787029 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Medical compression stocking (medical device name: mediven Harmony 734 (compression class1 AG armsleeve or with wide(735))
Description: Compression stockings worn on the arm or partial swelling of the hand after trauma or surgery.
Study NCT06358781 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Whole grain wheat flour
Description: Group A: whole grain flour: 0 g Group B: Whole grain flour: 25 g Group C: Whole grain flour: 50 g Group D: whole grain flour: 100g
Study NCT06204094 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: node-sparing short-course radiotherapy
Description: 5Gy\*5d, radiation targeting the tumor bed without irradiating surrounding tumor-draining lymph nodes
Study NCT06204094 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab
Description: 200mg intravenous infusion d1 of each cycle\*8cycles
Study NCT06204094 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: 1000mg/m2, PO, BID, d1-14 of each cycle\*8cycles
Study NCT06204094 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: 130mg/m2, intravenous infusion,d1 of each cycle\*8cycles
Study NCT06204094 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: TME surgery
Description: laparoscopic or robotic TME surgery for non-cCR patients
Study NCT06204094 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: watch and wait
Description: WW for cCR patients
Study NCT06327867 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Oro Tracheal Intubation by DL
Description: DL
Study NCT06327867 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Oro Tracheal Intubation by VL
Description: VL
Study NCT06263751 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Product prescription program- NutriConnect Credit
Description: Patient is given $20 credit to their Schnucks (grocery) Rewards account every other week for F\&V shopping. The Rewards credit can be used either through the Schnucks App or in store.
Study NCT06263751 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Product prescription program- NutriConnect Delivery
Description: Patient receives produce (F\&V) box (equivalent $20 value) delivered to home every other week. The items in the box will be pre-selected by Schnucks and the NutriConnect dieticians.
Study NCT06544707 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 0.003% AR-15512
Description: Ophthalmic solution administered via topical ocular instillation
Study NCT05976763 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Colonoscopy
Description: Undergo colonoscopy
Study NCT05976763 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Colonoscopy
Description: Undergo colonoscopy
Study NCT05976763 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT05715073 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: TeaCrine and Caffeine
Description: Participants will take Teacrine and caffeine then an hour later perform an intense interval exercise protocol followed by cognitive tests.
Study NCT05715073 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Caffeine
Description: Participants will take caffeine then an hour later perform an intense interval exercise protocol followed by cognitive tests.
Study NCT05715073 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will take the placebo cellulose pill and than an hour later perform an intense interval exercise protocol followed by cognitive tests.
Study NCT05976763 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT05976763 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT05976763 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT06581094 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: UCII, glucosamine and curcumin
Description: compound capsules twice daily.
Study NCT06581094 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo capsules twice daily.
Study NCT04931355 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: The Acupuncture intervention（Zhongwan、Qihai、Guanyuan、Zhongji、Guilai、Shenshu、Ciliao、Xuehai、Sanyinjiao、Taixi.） will start on the 5th day of menstruation cycle, which will be carried out 1 time per day, at least 5 times a week, lasts for 10-15days. All operations were performed by experienced acupuncturists. After ET, both the control group and the treatment group will be treated with conventionally with no TCM intervention.
Study NCT04931355 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Western medicine
Description: Western medicine
Study NCT06408623 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: chidamide combined with Sintilimab and bevacizumab
Description: chidamide combined with Sintilimab and bevacizumab
Study NCT05922787 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Reiki
Description: In the study, women received four Reiki sessions once a week for four weeks from the researchers with Usuı Shiki Ryoho Reiki 1
Study NCT04828447 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Olive Oil
Description: Subjects will be randomized to either high or low dose of olive oil and follow a whole food plant based diet.
Study NCT04199572 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Diclofenac and Paracetamol
Description: analgesic effect of diclofenac along with either Oral versus Intravenous paracetamol versus placebo
Study NCT05002855 — intervention group
Intervention type: OTHER
Intervention: Enhanced Recovery After Surgery (ERAS)
Description: Multidisciplinary approach to perioperative care.
Study NCT04287491 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Oculus Go Virtual Reality System
Description: The VR system will provide a 3D environment that provides distracting stimulus. Participant will put on the Oculus Go VR system headset 1-2 minutes prior to out-patient bedside procedure up to the completion of procedure which takes typically 3-5 minutes.
Study NCT05395806 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health App
Description: The intervention will include training health teams and patients in accessing and using a gamified health App 2-3 times a week. The App is based on a gamified character that improves its health if a patient checks its App, complies with her therapy, does regular exercise, and introduces normal levels of blood pressure, lipids level, and HbA1c levels. On the other hand, the character gets sick if the patient does not comply with her therapy or does not achieve certain levels of physical activity (i.e. 30 min moderate exercise 5 times a week or 2.5 hs a week or more than 9000 steps/day).
Study NCT05395806 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: In this group, participants will receive their usual cardiovascular care according to the national guidelines. All patients receive free care at the primary care clinics and also receive free medications prescribed according to the national guidelines at the clinics. In addition, participants in this group will receive specific written information to improve their medication compliance, level of physical activity, blood pressure, HbA1c, and lipids level control.
Study NCT06088706 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Intra-articular injection of ozone
Description: the patient is lying on the bed with his knee flexed at about 45 degrees. Then The syringe containing ozone is prepared by a sports medicine assistant and covered with a label so that the clinician is not aware of the injected ozone dose. Lateral Approach will be used for intra-articular injection. after preparation and drape of the desired position and aspiration, the ozone composition will be injected into the joint. In order to inject for this group, a 10 cc needle and a predetermined concentration of 20 and 40 micrograms ozone are used under sterile conditions. The duration of the injection will be 15-20 seconds. The number of sessions considered for injection will be three sessions, once a week for three weeks. The second and third injection will be done under the same conditions as the first session. In this study, Ozonette Sedecal device ( Spain) will be used. And the exercise therapy protocol is performed.
Study NCT06088706 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intra-articular injection of ozone
Description: the patient is lying on the bed with his knee flexed at about 45 degrees. Then The syringe containing ozone is prepared by a sports medicine assistant and covered with a label so that the clinician is not aware of the injected ozone dose. Lateral Approach will be used for intra-articular injection. after preparation and drape of the desired position and aspiration, the ozone composition will be injected into the joint. In order to inject for this group, a 10 cc needle and a predetermined concentration of 20 and 40 micrograms ozone are used under sterile conditions. The duration of the injection will be 15-20 seconds. The number of sessions considered for injection will be three sessions, once a week for three weeks. The second and third injection will be done under the same conditions as the first session. In this study, Ozonette Sedecal device ( Spain) will be used. And the exercise therapy protocol is performed.
Study NCT06088706 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Intra-articular injection of ozone
Description: the patient is lying on the bed with his knee flexed at about 45 degrees. Then The syringe containing ozone is prepared by a sports medicine assistant and covered with a label so that the clinician is not aware of the injected ozone dose. Lateral Approach will be used for intra-articular injection. after preparation and drape of the desired position and aspiration, the ozone composition will be injected into the joint. In order to inject for this group, a 10 cc needle and a predetermined concentration of 20 and 40 micrograms ozone are used under sterile conditions. The duration of the injection will be 15-20 seconds. The number of sessions considered for injection will be three sessions, once a week for three weeks. The second and third injection will be done under the same conditions as the first session. In this study, Ozonette Sedecal device ( Spain) will be used. And the exercise therapy protocol is performed.
Study NCT05040321 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MIB-626
Description: Participants will be randomized to either receive MIB-626 or matching placebo. The proposed intervention - targets multiple contributors to the pathology of AD; MIB-626 improves mitochondrial function, bioenergetics, and insulin sensitivity, inhibits A beta accumulation by reducing its synthesis and increasing its clearance, reduces neuroinflammation, exerts neuronal protective effects, and promotes neuronal regeneration and connectivity in preclinical models.
Study NCT05040321 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subjects will be randomized to receive either the placebo or 500mg MIB-626 twice daily orally.
Study NCT06190639 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sintilimab
Description: 200 mg once on day 1, every 21 days
Study NCT05810623 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intravesical Solution
Description: Intravesical single dose instillation of chemotherapy within 24h from uretero-renoscopy
Study NCT04541576 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Merit WRAPSODY Endovascular Stent Graft
Description: Target lesion treated with stent graft placement
Study NCT05230810 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alpelisib
Description: Orally twice a day
Study NCT05230810 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tucatinib
Description: Orally once a day
Study NCT05230810 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fulvestrant
Description: 500 mg intramuscularly into the buttocks slowly~\*Fulvestrant will be administered only in patients with HR+/HER2+ metastatic breast cancer
Study NCT06185504 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: systemic therapy
Description: All participants were given routine rehabilitation treatment by professional rehabilitation therapists, including exercise therapy, guided education, psychological therapy, acupuncture and massage therapy, to promote the development of motor and cognitive function, as well as to improve intellectual development\[. Besides, swallowing function training was also provided, including direct training, indirect training, and compensatory training, as follows~1. The mendelson maneuver: performed 5 days per week, twice per day, 5-10 minutes each time.~2. Cold stimulation of the pharynx: performed every day, twice per day, 3-5 minutes each time.~3. Passive head extension: to stretch the submental muscle for 2-3 seconds, with upward resistance applied to the lower cheek for no less than 5 times a day and no less than 5 minutes each time.~4. Direct feeding training: with powdered milk, once a day, 5 days a week.
Study NCT06185504 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: systemic therapy
Description: All participants were given routine rehabilitation treatment by professional rehabilitation therapists, including exercise therapy, guided education, psychological therapy, acupuncture and massage therapy, to promote the development of motor and cognitive function, as well as to improve intellectual development\[. Besides, swallowing function training was also provided, including direct training, indirect training, and compensatory training, as follows~1. The mendelson maneuver: performed 5 days per week, twice per day, 5-10 minutes each time.~2. Cold stimulation of the pharynx: performed every day, twice per day, 3-5 minutes each time.~3. Passive head extension: to stretch the submental muscle for 2-3 seconds, with upward resistance applied to the lower cheek for no less than 5 times a day and no less than 5 minutes each time.~4. Direct feeding training: with powdered milk, once a day, 5 days a week.
Study NCT06185504 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intermittent Oro-Esophageal Tube Feeding
Description: Within 4 hours of admission, the observation group were required to undergo nasogastric tube removal and initiated Intermittent Oro-Esophageal Tube Feeding for nutrition support. Before each feeding, the infant should rest for approximately 1 hour and undergo oral clean. During feeding, the infant should be held by the caregiver in a semi-reclined or upright position. Firstly, the tail of the tube was inserted via mouth into the upper part of the esophagus with a depth of 18-20cm, and the external part of the tube should be placed in water with the absence of bubbles indicating the successful tube placement. Subsequently, 1ml of water was slowly injected, followed by liquid food or water at a rate of approximately 50ml/min through a syringe connected to the feeding tube. After feeding, the tube should be slowly removed, and the feeding position should be maintained for 30-60 minutes to prevent reflux.
Study NCT06185504 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Persistent Nasogastric Tube Feeding
Description: The control group was given nutrition support with Persistent Nasogastric Tube Feeding, of which the tube passed through the nasal cavity into the stomach. After successful intubation, the tube was secured on the cheek. Liquid food was then syringe-fed into the stomach and the feeding was conducted every 2-3 hours, with each meal not exceeding 200 ml. The daily intake was generally consistent with that of the observation group. Besides, after successful intubation, the tube was secured on the infant's face and changed every one to two weeks.